QUOTE AND NEWS
PR Newswire  Oct 27  Comment 
SHENYANG, China, Oct. 27 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products,
PR Newswire  Oct 20  Comment 
SHENYANG, China, Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today
Motley Fool  Oct 8  Comment 
Yesterday's market is today's moneymaking road map.
PR Newswire  Sep 7  Comment 
SHENYANG, China, Sept. 6 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today
StreetInsider.com  Aug 11  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Earnings/3SBio+%28SSRX%29+Tops+Q2+Views/4866952.html for the full story.
China Securities  Aug 11  Comment 
Second quarter revenue grew 36.8% year-over-year to RMB81.5 million (US$11.9million) Operating income grew 69.9% year-over-year to RMB25.8 million (US$3.8 million) Company reiterates FY2009 revenue guidance SHENYANG, China, Aug. 11...
Motley Fool  Jul 31  Comment 
Maybe what glitters really is gold.
Motley Fool  Jul 9  Comment 
A lot of investors are missing the point. Are you?
Motley Fool  Jul 6  Comment 
And health-care spending should soar.
Motley Fool  Jul 1  Comment 
Another one-drug wonder immerges.
Suggest a News Source
Topic
Top news source/blog that we're missing
Why do you recommend this news source?
Close 
Thanks for your suggestion!
 


 
SSRX AT A GLANCE
P/E 48.0AVG
EV/EBITDA 41.2HIGH
ROA 3.7%AVG
ROE 3.8%AVG
Debt to Equity 0.0458VERY LOW
Current Ratio 21.3VERY HIGH
Interest Coverage Ratio 827VERY HIGH
 
 
 
 
 
 
 
 



References

Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki